BIO.News Newsletter

A new month—and the government’s not shut down. But there are still a few things we’re worried about, including proposed changes to Qualified Small Business Stock and proposed Prescription Drug Pricing Boards in several states. We explain why these are bad ideas. (782 words, 3 minutes, 54 seconds)

Expect a crazy day in D.C. as Congress prepares to vote on government funding and, maybe, infrastructure. Meanwhile, USDA announced a new climate-smart ag and forestry initiative. And, it’s Rare Cancer Day—here’s how we can help or hinder promising treatments. (904 words, 4 minutes, 31 seconds)

For Sickle Cell Awareness Month, we spoke to one patient advocate about her experience with the disease—and we explain why proposed drug price controls could make disparities in research even worse. We also have a lot of news on gene editing for food from around the world, and why it matters. (941 words, 4 minutes, 42 seconds)

The government’s not the only thing that might shut down. Proposed drug price controls could shut down investment in future cures and harm patients—today’s new episode of the I am BIO Podcast explains why. Plus, BIO IMPACT 2021 begins in one week—we have details about how BIO and our members are tackling climate. (811 words, 4 minutes, 3 seconds)

Washington’s on shutdown watch as Congress prepares to vote on government funding and infrastructure this week. Meanwhile, we tell you what you need to know about COVID vaccine boosters and how synbio’s all the rage in beauty and fashion. (719 words, 3 minutes, 35 seconds)

The House Agriculture Committee held a hearing on voluntary carbon markets yesterday—here’s what witnesses said about how we can ensure these markets work for farmers and the planet. And we bring you resources for a few health awareness days/months in September and explain why patient advocacy and visibility is so important. (821 words, 4 minutes, 6 seconds)

A busy week of global meetings continues with the start of the UN Food Systems Summit—a chance to build a more sustainable, resilient food supply with the help of biotech. Plus, we recap what happened during yesterday’s COVID-19 Summit and BIO’s response. (971 words, 4 minutes, 51 seconds)

It’s a busy day, with the UNGA COVID-19 summit (and a vaccine announcement from POTUS), a CDC advisory committee considering boosters, and the House working to avoid a government shutdown at the end of the month. Plus, it’s Car Free Day—but biotech could make this a thing of the past. (835 words, 4 minutes, 10 seconds)

Today, we explain why drug price controls amount to a “raid on future cures”—and why prescription drug prices aren’t the problem anyway. Plus, we look at Gingko Bioworks’ history-making IPO and what it means for synbio. (681 words, 3 minutes, 24 seconds)

Starting the new week—and the UN General Assembly—with a focus on two of our world’s most pressing issues: climate change and antimicrobial resistance. Luckily, biotechnology offers solutions for both, if we get policy right. (700 words, 3 minutes, 30 seconds)